Investor Keeps Buying This Nuclear ETF Through March Rally
An anonymous investor continues to buy the VanEck Uranium and Nuclear ETF every month, betting on nuclear power's lon...
Regular budget checks are essential for resilience, catching shifts in income or needs and guiding timely adjustments toward stability.
20,170 articlesAn anonymous investor continues to buy the VanEck Uranium and Nuclear ETF every month, betting on nuclear power's lon...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
This week brought a notable rise for Corcept Therapeutics as investors reacted to a major catalyst. Learn what drove ...
Investors are watching whether NVIDIA back business China could unlock a new revenue stream. This analysis covers sce...
Oil weakness and a tech-led stock rally push the VIX toward the 17 level as traders return to equities.
Apple and Intel are reportedly exploring a U.S.-based chip supply and manufacturing pact. The talks, if they advance,...
Oil markets are in flux, and Occidental faces a pivotal year. This guide breaks down what to expect from occidental (...
At Consensus 2026 in Miami, Pi Network’s Dr. Chengdiao Fan laid out a vision for utility-driven tokens and real-world...
A practical, plain‑language breakdown of Navigator NVGS's Q1 2026 earnings trajectory. Learn what drives revenue, how...
BBB Foods reports Q1 2026 results with modest revenue growth and steadier margins. This review translates the transcr...
Montauk’s early 2026 numbers offer critical clues for shareholders. This guide breaks down the montauk (mntk) 2026 ea...
When a company director trims a stake, investors ask: what does it mean for the stock? This guide walks you through h...